$46.26 0.76 (+1.67%)
11/6/2009 4:00 PM

Gilead Sciences, Inc. (GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Featured Broker Partners